The study also linked COVID-19 to a 60% to 97% increased rate of preterm birth, and— in infected women with a fever and shortness of breath—to a fivefold increase in neonatal complications such as immature lungs, brain damage, and eye disorders. About 13% of babies tested positive for the virus, and cesarean delivery was linked to a higher risk of transmission. Breastfeeding didn’t appear to transmit the virus—a small bit of good news.
New study bolsters the case for vaccinating pregnant women.
Mice fed every other day in another study lived, on average, 12% longer than mice fed every day, largely due to the delay of cancerous diseases.
Affiliate Disclaimer: Longevity Advice is reader-supported. When you buy something using links on our site, we may earn a few bucks.
According to the International Food Information Council’s 2020 Food and Health Survey, you most likely know someone who is practicing intermittent fasting. The survey of 1000 adult Americans found that one in ten were putting down the fork during specified periods of time, making it America’s most popular “diet.”
It’s no surprise that the diet has charmed so many Americans. Intermittent fasting is the preferred diet of celebrities, from Kourtney Kardashian to Twitter CEO Jack Dorsey, and is reportedly a staple of Silicon Valley culture. Fox News reported that it’s “hailed by trainers [and] doctors as [an] easy weight loss program that works.”
A new study by American researchers from Kansas State University and Agricultural Research Service have alarmingly found that house flies can carry the SARS-CoV-2 coronavirus for up to 24 hours after exposure and are potential transmission vectors of the SARS-CoV-2 coronavirus!
House flies are known to transmit bacterial, parasitic and viral diseases to humans and animals as mechanical vectors. Previous studies have shown that house flies can mechanically transmit coronaviruses, such as turkey coronavirus; however, the house fly’s role in SARS-CoV-2 transmission was not explored until now. The goal of the study was to investigate the potential of house flies to mechanically transmit SARS-CoV-2.
The work adds to a growing body of evidence suggesting that schizophrenia and certain other neuropsychiatric conditions may be in part neuroinflammatory disorders.
Summary: People with schizophrenia and other neuropsychiatric disorders may have a more permissive blood-brain barrier which allows the immune system to become more actively involved in the central nervous system. The resulting inflammation may contribute to the clinical manifestation of psychosis-like symptoms.
Source: University of Pennsylvania
Like a stern bodyguard for the central nervous sytem, the blood-brain barrier keeps out anything that could lead to disease and dangerous inflammation–at least when all is functioning normally.
That may not be the case in people with schizophrenia and other mental disorders, suggest new findings from a team led by researchers from the School of Veterinary Medicine, Perelman School of Medicine, and Children’s Hospital of Philadelphia (CHOP).
The U.S. spends more per person on prescription drugs than any other nation, and spending on cancer drugs has more than doubled since 2013 to over $60 billion annually, according to the data firm IQVIA. New medications typically cost $90000 to $300000 a year. And those prices have risen much faster than patient survival.
Each year the U.S. approves dozens of new uses for cancer drugs based on early signs that they can shrink or slow the spread of tumors.
A 3D biomaterial scaffold design to slowly release stem cells ensures that implanted stem cells stick around to relieve pain and reverse arthritis in mice knee joints. This reduces the use of stem cells by 90%, thus avoiding the challenge of redness, swelling and scar tissue that can arise from large doses of such stem cells, and potentially opening a path to reversal of osteoarthritis in humans for the first time.
The results were published in the Chemical Engineering Journal on February 25.
There is currently no treatment that can reverse the course of osteoarthritis, and our sole options are to try to relieve pain. Stem cell therapy potentially offers hope and has been shown to alienate the disease, but a ‘goldilocks’ dose of stem cells remains out of reach. Too much of a dose of stem cells and the subject suffers redness, swelling and scar tissue. Too little and the therapy is only successful for a limited period due to gradual cell loss.
Lockheed Martin Space hired 2700 people plus 700 interns in 2020, a year unlike any other for human resources managers. Almost overnight, the prime contractor with about 23000 employees switched from its traditional in-person approach to virtual recruitment, interviewing and training.
SpaceNews correspondent Debra Werner spoke with Lockheed Martin Space executives Nick Spain, human resources vice president, Renu Aggarwal, talent acquisition director, and Heather Erickson, organizational development director, about the opportunities and challenges posed by heightened demand for talent amid a pandemic.
The only thing bad about Star Trek was they made the Borg evil.
Emerging technologies have unprecedented potential to solve some of the world’s most pressing issues. Among the most powerful — and controversial — is the gene-editing tech, CRISPR-Cas9, which will improve agricultural yields, cure genetic disorders, and eradicate infectious diseases like malaria. But CRISPR and other disruptive technologies, like brain-machine interfaces and artificial intelligence, also pose complex philosophical and ethical questions. Perhaps no one is better acquainted with these questions than Peter Diamandis, founder of the XPRIZE Foundation and co-founder of Singularity University and Human Longevity Inc. In this session, Peter will give a state of the union on the near future and explore the profound ethical implications we will face in the ongoing technological revolution.
This talk was recorded at Summit LA19.
Interested in attending Summit events? Apply to attend : https://summit.co/apply.
Connect with us:
“More than 100 malaria vaccine candidates have entered clinical trials in recent decades, but none has shown efficacy greater than 75% – until now.” https://www.futuretimeline.net/images/socialmedia/
Researchers led by the University of Oxford have completed a Phase II trial of R21/Matrix-M, a candidate malaria vaccine, which demonstrated an efficacy of 77% over 12-months of follow-up.
In their findings, posted on SSRN/Preprints with The Lancet, they note that their study is the first to reach the World Health Organization’s goal for a vaccine with at least 75% efficacy by 2030. It represents a substantial improvement over the current most effective malaria vaccine, which has shown just 55% efficacy in trials on African children.
The authors conducted a randomised, controlled, double-blind trial at the Clinical Research Unit of Nanoro (CRUN) / Institut de Recherche en Sciences de la Santé (IRSS), in the West African country of Burkina Faso. They recruited 450 participants, aged 5–17 months, from the catchment area of Nanoro, covering 24 villages and a population of 65000 people.